CHINA SHINEWAY PHARMACEUTICAL GROUP LIMITED (02877) reported no changes to its authorized share capital or issued shares as of October 31, 2025. The company's authorized share capital remained at HKD 500,000,000, comprising 5,000,000,000 ordinary shares at a par value of HKD 0.1 each. Issued shares remained at 827,000,000, and no treasury shares were reported. No movements were disclosed for share options, warrants, convertibles, or any similar arrangements during the reporting period.